Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

University of Toronto

$988,617.00

Role of colonic short chain fatty acids in obesity and insulin resistance

FY 2008-09

Summary
The high rate of obesity in Canada is a major public health concern because obesity increases risk for diseases such as diabetes and heart disease. Research shows that people who eat a high amount of dietary fiber gain less weight and are at lower risk of getting diabetes than those with low fiber diets. This may be because fibers are broken down (fermented) by bacteria in the large intestine (colon) to form gases (the cause of flatulence) and substances known as short chain fatty acids (SCFA). The most abundant SCFA is acetic acid, which is commonly consumed in vinegar. SCFA may be beneficial; our research shows that they influence the secretion of hormones such as glucagon-like peptide 1 (GLP-1), peptide YY (PYY), ghrelin and adiponectin which help control appetite and blood glucose levels. On the other hand, research suggests that obese people have different bacteria in their colons which break down fiber to produce more SCFA than lean people and that this causes weight gain because of the extra energy obtained from the SCFA. However, it is unknown if obese people produce more SCFA or not. The purpose of this research is to see if the types of colonic bacteria, and the absorption, metabolism and metabolic effects of SCFA differ in lean and obese subjects. Using a series of tests in human subjects involving intravenous and rectal infusion of acetate and measuring blood SCFA responses after feeding a fermentable fiber we will determine the rates of production, absorption and metabolism of acetate in lean and obese subjects and in people with different kinds of bacteria in their colons and whether these treatments have different effects on hormones and metabolites which control appetite and blood glucose. This research will help us to understand if and how colonic SCFA are involved in the development of obesity in humans so that treatments can be developed to help correct the problem(s) identified and ultimiately help to prevent or treat obe
Program
Operating Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
179933
Name
Wolever Thomas M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Nutrition, Food & Health
Projecttitle
Role of colonic short chain fatty acids in obesity and insulin resistance
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$988,617
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Colonic Fermentation; Gut Hormones; Humans; Insulin Sensitivity; Obesity; Whole Body Metabolism
Abstract
The high rate of obesity in Canada is a major public health concern because obesity increases risk for diseases such as diabetes and heart disease. Research shows that people who eat a high amount of dietary fiber gain less weight and are at lower risk of getting diabetes than those with low fiber diets. This may be because fibers are broken down (fermented) by bacteria in the large intestine (colon) to form gases (the cause of flatulence) and substances known as short chain fatty acids (SCFA). The most abundant SCFA is acetic acid, which is commonly consumed in vinegar. SCFA may be beneficial; our research shows that they influence the secretion of hormones such as glucagon-like peptide 1 (GLP-1), peptide YY (PYY), ghrelin and adiponectin which help control appetite and blood glucose levels. On the other hand, research suggests that obese people have different bacteria in their colons which break down fiber to produce more SCFA than lean people and that this causes weight gain because of the extra energy obtained from the SCFA. However, it is unknown if obese people produce more SCFA or not. The purpose of this research is to see if the types of colonic bacteria, and the absorption, metabolism and metabolic effects of SCFA differ in lean and obese subjects. Using a series of tests in human subjects involving intravenous and rectal infusion of acetate and measuring blood SCFA responses after feeding a fermentable fiber we will determine the rates of production, absorption and metabolism of acetate in lean and obese subjects and in people with different kinds of bacteria in their colons and whether these treatments have different effects on hormones and metabolites which control appetite and blood glucose. This research will help us to understand if and how colonic SCFA are involved in the development of obesity in humans so that treatments can be developed to help correct the problem(s) identified and ultimiately help to prevent or treat obe
Competitiondate
200903
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Wolever, Thomas M
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $988,617~ $0~
University of Toronto - $988,617 Grant (2008-09) | Canada Spends